Trials / Completed
CompletedNCT00406926
The Effect of Growth Hormone in Very Young Girls With Turner Syndrome
The Effect of Recombinant Human Growth Hormone Treatment on the Growth of Infants and Toddlers With Turner Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Female
- Age
- 9 Months – 4 Years
- Healthy volunteers
- Not accepted
Summary
This study investigated the effect of growth hormone on the growth of infants and toddlers with Turner syndrome during 2 years of treatment with growth hormone. This was compared with the growth of infants and toddlers with Turner syndrome who did not receive any growth hormone treatment. The overall aim was to prevent the growth failure usually seen during this period. The study also looked at middle ear disease, hearing problems, and cognitive and behavioral development.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Somatropin |
Timeline
- Start date
- 1999-08-01
- Completion
- 2003-08-01
- First posted
- 2006-12-04
- Last updated
- 2006-12-04
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00406926. Inclusion in this directory is not an endorsement.